U.S. markets open in 6 hours 47 minutes

Acutus Medical, Inc. (AFIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.06-0.53 (-5.53%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close9.59
Open9.46
Bid0.00 x 800
Ask0.00 x 1000
Day's Range8.63 - 9.46
52 Week Range8.63 - 34.35
Volume483,100
Avg. Volume377,106
Market Cap253.153M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-4.72
Earnings DateNov 10, 2021 - Nov 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Acutus Medical, Inc.
    Daily – Vickers Top Buyers & Sellers for 08/13/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more
  • Motley Fool

    Acutus Medical, Inc. (AFIB) Q2 2021 Earnings Call Transcript

    AFIB earnings call for the period ending June 30, 2021.

  • Zacks

    Acutus Medical, Inc. (AFIB) Reports Q2 Loss, Tops Revenue Estimates

    Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 11.00% and 1.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Acutus Medical Appoints Niamh Pellegrini to Board of Directors

    CARLSBAD, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the appointment of Niamh Pellegrini to the Company's Board of Directors, effective August 10, 2021. Ms. Pellegrini has over 20 years of experience in the healthcare industry and, since July 2019, has served as the Chief Commercial Officer of Nevro, Inc., a medical device company d